Bandingkan Harga & Kinerja Indonesia Fibreboard Industry Tbk. (IFII) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indonesia Fibreboard Industry Tbk. dan Organon Pharma Indonesia Tbk.: Indonesia Fibreboard Industry Tbk. diperdagangkan di Rp222 (kapitalisasi pasar 1,88 T, volume 24 jam 24,34 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indonesia Fibreboard Industry Tbk. jauh lebih besar — sekitar 18× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IFII | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,88 T | 104,4 M |
Volume | 24,34 jt | — |
Lot | 243,4 rb | — |
Perputaran | 6,22 M | — |
Harga Rata-rata | 255,4 | — |
Nilai Transaksi | 6,22 M | — |
Harga Ekuilibrium Indikatif | 222 | — |
Volume Ekuilibrium Indikatif | 2,6 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indonesia Fibreboard Industry Tbk.
PT Indonesia Fibreboard Industry Tbk (the Company) was established based on the notarial deed No. 94 dated September 24, 2007 from Johny Dwikora Aron, S.H., Notary in Jakarta.
Selengkapnya di halaman IFII →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
